Products
IP Reports
Search
Patexia Concierge
Patent Analyzer
Trademark Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us
Search
Login
Join
Patexia
Research
Case number
IPR2023-00724
Lawsuits
Summary
Related Cases
Documents
Discussions
Mylan Pharmaceuticals Inc. et al. v. Novo Nordisk A/S > Related Cases
Number
Title
Filing date
1:22-cv-00294
Novo Nordisk Inc. et al v. Rio Biopharmaceuticals, Inc. et al
Mar 4, 2022
1:22-cv-00295
Novo Nordisk Inc. et al v. Aurobindo Pharma USA, Inc. et al
Mar 4, 2022
1:22-cv-00296
Novo Nordisk A/S et al v. Sun Pharmaceutical Industries Ltd. et al
Mar 4, 2022
1:22-cv-00298
Novo Nordisk Inc. et al v. Dr. Reddy's Laboratories Ltd. et al
Mar 4, 2022
1:22-cv-00299
Novo Nordisk Inc. et al v. Alvogen, Inc.
Mar 4, 2022
1:22-cv-00297
Novo Nordisk Inc. et al v. Zydus Worldwide DMCC et al
Mar 4, 2022
1:22-cv-00023
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
Mar 18, 2022
1:22-md-03038
In Re: Ozempic (Semaglutide) Patent Litigation
Aug 5, 2022
1:22-cv-01040
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
Aug 8, 2022
IPR2024-00009
DR. REDDY'S LABORATORIES, INC. et al. v. Novo Nordisk A/S
Oct 20, 2023
IPR2024-00107
Sun Pharmaceutical Industries Ltd. et al. v. Novo Nordisk A/S
Nov 2, 2023
IPR2024-00631
Apotex Inc. et al. v. Novo Nordisk A/S
Mar 1, 2024
2nd Annual Patexia Mixer
Our second Mixer will be on January 18th in Santa Monica. Make sure to
Register Today
Menu
Log In
Products
IP Reports
Search
Patexia Concierge
Patent Analyzer
Trademark Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us